ClinicalTrials.Veeva

Menu

Shnaghai Shengkang Medical Center

G

Guoxiang Fu

Status

Unknown

Conditions

Vascular Diseases

Study type

Observational

Funder types

Other

Identifiers

NCT03334474
shengkang

Details and patient eligibility

About

The process of population aging that is occurring in developed societies represents a major challenge for the health system. The aim of this study is to analyze factors that have an influence on early vascular aging (EVA), estimated by carotid-femoral pulse wave velocity (cf-PWV) and Cardio Ankle Vascular Index (CAVI), and to determine differences by gender in a Chinese population.

Enrollment

1,000 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • • Patients aged 35 to 85 years who agree to participate in the study and do not meet any of the exclusion criteria.

Exclusion criteria

  • • Subjects who are in terminal condition, who cannot travel to the health centers to undergo the corresponding examinations, and those who do not wish to sign the informed consent.

    • Subjects with a history of CVD (ischemic heart disease or stroke, peripheral arterial disease or heart failure), diagnosed renal failure in terminal stages (glomerular filtration rate below 30%), chronic inflammatory disease, or acute inflammatory process in the past three months.
    • Patients treated with estrogens, testosterone, or growth hormone.

Trial design

1,000 participants in 3 patient groups

young
Description:
18-35 years old
middle
Description:
35-65 years old
aged
Description:
65-85 years old

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems